Regenxbio RGNX Income Statement (2014-2026)

NASDAQ RGNX
$7.69 -0.38 (-4.71%)
At close: Nov 10, 2026 · 4:00 PM EST
Reported Financials

Regenxbio Quarterly Income Statement

Periods 48 quarters
Latest Jun 2026

Regenxbio reported revenue of $108.02M and net income of $22.69M for the quarter ended Jun 2026, up 405.7% year over year. This income statement covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income StatementIncome Statement Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
30.77M398.66M22.22M32.65M26.51M31.35M19.14M19.98M28.91M22.21M15.62M22.30M24.20M21.21M89.01M21.36M29.73M30.34M108.02M
Cost of RevenueCost of Rev
14.11M23.06M15.72M12.95M13.09M12.78M4.11M9.48M12.39M11.24M4.28M10.58M12.39M6.32M
Gross Profit
16.67M375.60M6.50M19.70M13.42M18.56M15.03M10.50M16.53M10.98M11.34M11.72M11.81M14.90M
Operating items
Research & DevelopmentR&D
47.86M47.98M55.63M61.01M63.31M62.51M58.52M59.89M58.18M55.68M54.84M48.87M54.43M50.38M53.09M59.50M56.10M59.61M56.09M
Selling, General & AdministrativeSG&A
21.03M22.04M22.32M20.83M20.92M21.21M22.63M23.70M23.08M19.08M18.29M18.86M19.42M20.05M20.35M19.88M20.25M22.38M21.62M
Other Operating ExpensesOther Opex
19.24M15.04M0.08M0.39M0.23M5.40M0.03M0.03M0.22M11.36M6.35M10.61M0.04M2.15M3.45M5.25M5.79M5.98M1.05M
Operating ExpensesOpex
88.12M85.06M93.75M95.18M97.56M89.12M85.30M93.09M93.87M86.12M79.49M78.33M86.28M72.58M76.89M84.64M82.14M87.97M78.76M
Operating IncomeOp. Inc
-57.35M313.60M-71.53M-62.53M-71.05M-57.77M-66.16M-73.11M-64.96M-63.90M-63.86M-56.04M-62.08M-51.37M12.13M-63.28M-52.41M-57.64M29.26M
Non-operating items
Non Operating Interest Expenses
6.71M6.50M6.13M6.86M5.95M4.31M2.76M1.12M1.62M1.36M1.97M0.45M0.82M9.42M8.57M10.99M13.17M12.28M7.79M
Interest & Investment IncomeInt & Inv Inc
5.54M0.31M0.80M1.06M1.50M2.03M2.17M2.13M4.66M2.37M2.47M3.47M3.28M9.52M2.50M3.38M3.62M2.75M1.22M
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
-1.06M-6.17M-5.24M-5.65M-4.44M-2.21M-0.52M1.05M3.09M0.86M0.53M3.05M2.48M0.18M-6.04M-7.59M-9.53M-9.51M-6.55M
Net income details
EBIT
-57.35M313.60M-71.53M-62.53M-71.05M-57.77M-66.16M-73.11M-64.96M-63.90M-63.86M-56.04M-62.08M-51.37M12.13M-63.28M-52.41M-57.64M29.26M
EBT
-58.41M307.43M-76.76M-68.18M-75.48M-59.98M-66.68M-72.06M-61.87M-63.04M-63.37M-53.02M-59.62M-51.27M6.06M-70.89M-61.96M-67.17M22.69M
Tax ProvisionsTaxes
13.40M-0.04M-0.04M
Income After Tax
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-63.04M-63.37M-53.02M-59.62M-51.27M6.06M-70.89M-61.96M-67.17M22.69M
Income from Continuing OperationsIncome (Continuing)
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-63.04M-63.37M-53.02M-59.62M-51.27M6.06M-70.89M-61.96M-67.17M22.69M
Consolidated Net IncomeConsol Net Inc.
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-63.04M-63.37M-53.02M-59.62M-51.27M6.06M-70.89M-61.96M-67.17M22.69M
Income towards Parent CompanyParent Net Inc
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-62.89M-63.33M-52.99M-59.60M-51.19M6.08M-70.87M-61.94M-67.15M22.71M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-58.41M294.02M-76.72M-68.18M-75.48M-59.94M-66.68M-72.06M-61.87M-62.89M-63.33M-52.99M-59.60M-51.19M6.08M-70.87M-61.94M-67.15M22.71M
Additional items
EPS (Basic)
-1.376.93-1.79-1.58-1.75-1.39-1.53-1.66-1.41-1.44-1.38-1.05-1.17-1.030.12-1.38-1.20-1.300.43
EPS (Diluted)
-1.376.70-1.79-1.58-1.75-1.39-1.53-1.66-1.41-1.44-1.38-1.05-1.17-1.030.12-1.38-1.20-1.300.43
Shares Outstanding
42.63M42.44M42.94M43.11M43.25M43.15M43.45M43.53M43.95M43.73M45.73M50.60M50.80M49.51M51.36M51.48M51.69M51.57M52.82M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
42.63M43.91M42.94M43.11M43.25M43.15M43.45M43.53M43.95M43.73M45.73M50.60M50.80M49.51M51.43M51.48M51.69M51.57M53.02M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
42.75M42.83M42.98M43.17M43.29M43.30M43.47M43.62M43.99M44.05M49.04M49.32M49.53M49.55M50.12M50.39M50.62M50.89M54.16M
EBITDA
-54.52M316.24M-68.94M-59.89M-67.50M-53.65M-61.98M-68.67M-60.59M-59.57M-59.68M-51.99M-58.12M-47.35M16.08M-59.37M-48.53M-53.77M-79.51M33.02M
Interest ExpensesInt Expense
6.71M6.50M6.13M6.86M5.95M4.31M2.76M1.12M1.62M1.36M1.97M0.45M0.82M9.42M8.57M10.99M13.17M12.28M7.79M
Tax Rate
4.36%

Regenxbio Income Statement API

Pull Regenxbio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RGNX&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY